PEGORARO, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 23.160
EU - Europa 3.898
AS - Asia 3.822
SA - Sud America 156
AF - Africa 34
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 8
Totale 31.094
Nazione #
US - Stati Uniti d'America 23.120
SG - Singapore 1.896
CN - Cina 1.256
IT - Italia 956
FI - Finlandia 551
SE - Svezia 516
DE - Germania 465
HK - Hong Kong 336
FR - Francia 304
UA - Ucraina 299
GB - Regno Unito 252
VN - Vietnam 235
RU - Federazione Russa 222
BR - Brasile 140
NL - Olanda 81
IE - Irlanda 79
AT - Austria 50
IN - India 34
CA - Canada 30
TR - Turchia 24
CH - Svizzera 20
PL - Polonia 16
CI - Costa d'Avorio 15
BE - Belgio 14
AU - Australia 11
GR - Grecia 11
ES - Italia 10
RO - Romania 10
MA - Marocco 9
EU - Europa 8
LT - Lituania 8
MX - Messico 7
AR - Argentina 6
CZ - Repubblica Ceca 6
HU - Ungheria 6
JP - Giappone 6
BG - Bulgaria 5
IQ - Iraq 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
TW - Taiwan 5
ZA - Sudafrica 4
EC - Ecuador 3
IR - Iran 3
PK - Pakistan 3
SA - Arabia Saudita 3
SI - Slovenia 3
BD - Bangladesh 2
CL - Cile 2
CO - Colombia 2
EG - Egitto 2
HR - Croazia 2
ID - Indonesia 2
IL - Israele 2
KZ - Kazakistan 2
OM - Oman 2
PT - Portogallo 2
RS - Serbia 2
SC - Seychelles 2
UZ - Uzbekistan 2
VE - Venezuela 2
AL - Albania 1
BN - Brunei Darussalam 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GT - Guatemala 1
HN - Honduras 1
KE - Kenya 1
LU - Lussemburgo 1
NP - Nepal 1
PH - Filippine 1
PY - Paraguay 1
TH - Thailandia 1
Totale 31.094
Città #
Fairfield 3.684
Woodbridge 2.328
Houston 2.015
Ann Arbor 1.666
Chandler 1.419
Ashburn 1.406
Seattle 1.306
Jacksonville 1.251
Wilmington 1.244
Cambridge 1.228
Singapore 823
Boardman 635
Princeton 541
San Diego 481
Santa Clara 338
Hong Kong 334
Medford 334
Roxbury 325
Beijing 285
Padova 242
Dong Ket 234
Des Moines 229
Helsinki 209
Nanjing 194
Milan 98
Guangzhou 90
Dublin 79
Shenyang 79
New York 76
Nuremberg 76
Hebei 64
London 59
Nanchang 57
Norwalk 52
Ogden 48
Jiaxing 41
Tianjin 40
Shanghai 34
Jinan 31
Changsha 30
Lappeenranta 30
Los Angeles 28
Kharkiv 23
Rome 21
Falkenstein 20
Redwood City 20
Phoenix 19
Chicago 17
Vienna 16
Abidjan 15
Borås 15
Detroit 15
Las Vegas 15
Ningbo 15
Borgosatollo 14
Kilburn 14
Munich 14
Ovada 14
Prescot 14
Washington 14
Zhengzhou 14
Dallas 13
Hounslow 13
Bologna 12
Brescia 12
The Dalles 12
Frankfurt am Main 10
Morges 10
Tappahannock 10
Verona 10
Falls Church 9
Hangzhou 9
Hefei 9
Indiana 9
Kunming 9
Selvazzano Dentro 9
Mogliano Veneto 8
Paris 8
Rockville 8
São Paulo 8
Toronto 8
Turin 8
Venice 8
Chiswick 7
Dearborn 7
Naples 7
Ottawa 7
Rio de Janeiro 7
Treviso 7
Waanrode 7
Amsterdam 6
Ferrara 6
Florence 6
Istanbul 6
Pontedera 6
Pune 6
Redmond 6
Vigonza 6
Brussels 5
Casablanca 5
Totale 24.391
Nome #
Non-neural phenotype of spinal and bulbar muscular atrophy: Results from a large cohort of Italian patients 203
Specific numerical processing impairment in ALS patients 188
"Mitochondrial neuropathies": A survey from the large cohort of the Italian Network 178
Increased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients 177
SPP1 genotype and glucocorticoid treatment modify osteopontin expression in Duchenne muscular dystrophy cells 177
null 171
Improving the knowledge of amyotrophic lateral sclerosis genetics: novel SOD1 and FUS variants. 162
Health-related quality of life and functional changes in DMD:A 12-month longitudinal cohort study 159
Unimpaired Neuropsychological Performance and Enhanced Memory Recall in Patients with Sbma: A Large Sample Comparative Study. 158
Pachymeningeal involvement in POEMS syndrome: MRI and histopathological study. 156
Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies 153
Parkinson-like features in ALS with predominant upper motor neuron involvement 153
ALS risk but not phenotype is affected by ataxin-2 intermediate length polyglutamine expansion 148
Cardiomyopathy in patients with POMT1-related congenital and limb-girdle muscular dystrophy. 146
Progress in enzyme replacement therapy in glycogen storage disease type II 144
A novel SACS mutation results in non-ataxic spastic paraplegia and peripheral neuropathy. 144
Functional changes in Becker muscular dystrophy: Implications for clinical trials in dystrophinopathies 142
Polyglutamine-Expanded Androgen Receptor Alteration of Skeletal Muscle Homeostasis and Myonuclear Aggregation Are Affected by Sex, Age and Muscle Metabolism 141
Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2 138
TGFB2R but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscle. 137
Muscle MRI and functional outcome measures in Becker muscular dystrophy 134
New FIG4 gene mutations causing aggressive ALS 132
The m.3243A>G mitochondrial DNA mutation and related phenotypes. A matter of gender? 131
1st International Workshop on Clinical trial readiness for sarcoglycanopathies 15-16 November 2016, Evry, France 131
SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy 130
New motor outcome function measures in evaluation of Late-Onset Pompe disease before and after enzyme replacement therapy 128
Reliable and versatile immortal muscle cell models from healthy and myotonic dystrophy type 1 primary human myoblasts 128
Abnormal cochlear potentials in Friedreich's ataxia point to disordered synchrony of auditory nerve fiber activity 127
Vaccination recommendations for patients with neuromuscular disease 126
Motor neuron disease in the Padua district of Italy: an epidemiological study 125
Survival and quality of life after tracheostomy for acute respiratory failure in patients with amyotrophic lateral sclerosis 125
Muscle MRI in patients with dysferlinopathy: Pattern recognition and implications for clinical trials 125
Genetic modifiers of Duchenne muscular dystrophy and dilated cardiomyopathy 123
Collagen VI is required for the structural and functional integrity of the neuromuscular junction 123
X-inactivation pattern in multiple tissues from two Leber's hereditary optic neuropathy (LHON) patients 121
Myoclonus in mitochondrial disorders. 121
Frequency of LGMD gene mutations in Italian patients with distinct clinical phenotypes 121
Enzyme replacement therapy improves respiratory outcomes in patients with late-onset type II glycogenosis and high ventilator dependency 121
24 month longitudinal data in ambulant boys with duchenne muscular dystrophy. 120
Cognitive profile and MRI findings in limb-girdle muscular dystrophy 2I 120
POMT1 and POMT2 mutations in CMD patients: A multicentric Italian study 118
Targeted gene panel screening is an effective tool to identify undiagnosed late onset Pompe disease 118
A mobile app for patients with Pompe disease and its possible clinical applications 118
Clinical and molecular characterization of limb girdle muscular dystrophy due to LAMA2 mutations. 117
Genetic modifiers of respiratory function in Duchenne muscular dystrophy 116
Aberrant Compartment Formation by HSPB2 Mislocalizes Lamin A and Compromises Nuclear Integrity and Function 116
The italian limb girdle muscular dystrophy registry: Relative frequency, clinical features, and differential diagnosis 115
Elevated TGF β2 serum levels in Emery-Dreifuss Muscular Dystrophy: Implications for myocyte and tenocyte differentiation and fibrogenic processes 115
Reliability of the North Star Ambulatory Assessment in a multicentric setting 114
Epidemiology of ALS in Padova district, Italy, from 1992 to 2005 114
MRI in the assessment of muscular pathology: a comparison between limb-girdle muscular dystrophies, hyaline body myopathies and myotonic dystrophies. 113
Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease 112
Prevention of extubation failure in high-risk patients with neuromuscular disease 111
Androgen-dependent impairment of myogenesis in spinal and bulbar muscular atrophy. 110
Right hemisphere dysfunction and emotional processing in ALS: an fMRI study 110
Safety and efficacy of edaravone compared to historical controls in patients with amyotrophic lateral sclerosis from North-Eastern Italy 110
Duchenne phenotype with in-frame deletion removing major portion of dystrophin rod: threshold effect for deletion size? 109
MYH7 gene mutation in myosin storage myopathy and scapulo-peroneal myopathy 109
Gene expression profiling in dysferlinopathies using a dedicated muscle microarray 109
Clinical and molecular study in a long-surviving patient with MLASA syndrome due to novel PUS1 mutations 109
Insights into the genetic epidemiology of SBMA: prevalence estimation and multiple founder haplotypes in the Veneto Italian region. 109
P. 5.7 Limb-girdle muscular dystrophy type 2E: Clinical, genetic and histopathological features of 27 European patients 108
Assessment of patients with idiopathic inflammatory myopathies and isolated creatin-kinase elevation 108
Next Generation Molecular Diagnosis of Hereditary Spastic Paraplegias: An Italian Cross-Sectional Study 108
A checklist for clinical trials in rare disease: Obstacles and anticipatory actions-lessons learned from the FOR-DMD trial 107
LMNA-associated myopathies: the Italian experience in a large cohort of patients 106
LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population 106
CAG repeat length in androgen receptor gene is not associated with amyotrophic lateral sclerosis. 105
SERCA1 protein expression in muscle of patients with Brody disease and Brody syndrome and in cultured human muscle fibers. 105
Neutral Lipid Storage Diseases: clinical/genetic features and natural history in a large cohort of Italian patients 105
Duchenne muscular dystrophy and myotonic dystrophy in the same patient. 104
The role of AR polyQ tract in male breast carcinoma: lesson from an SBMA case 104
Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy. 103
Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1-3 D4Z4 reduced alleles: Experience of the FSHD Italian National Registry 103
Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females. 103
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. 103
Teaching an old molecule new tricks: Drug repositioning for duchenne muscular dystrophy 103
Dystrophinopathies 102
Cerebellar ataxia and coenzyme Q10 deficiency 102
Quality of life and motor impairment in ALS: Italian validation of ALSAQ 102
Sphingomonas paucimobilis associated with localised calf myositis 102
Mutation Analysis of MFN2, GJB1, MPZ and PMP22 in Italian Patients with Axonal Charcot-Marie-Tooth Disease. 102
Cardiac involvement in Becker muscular dystrophy 101
Phenotypic heterogeneity of the 8344A>G mtDNA "MERRF" mutation. 101
A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes 101
Congenital muscular dystrophies with cognitive impairment A population study 101
Redefining phenotypes associated with mitochondrial DNA single deletion 100
Deflazacort in Duchenne dystrophy: study of long term effect 99
Memory deficits and retrieval processes in ALS 99
Telethon Network of Genetic Biobanks: a key service for diagnosis and research on rare diseases. 99
Validation of the Italian version of the SBMA Functional Rating Scale as outcome measure 99
RNA metabolism in myotonic dystrophy: patient muscle shows decreased insulin receptor RNA and protein consistent with abnormal insulin resistance. 99
TDP-43 in skeletal muscle of patients affected with amyotrophic lateral sclerosis 98
Neuropsychological and endocrinological study in myotonic dystrophy type 1 98
Observational clinical study in juvenile-adult Glycogenosis type 2 patients undergoing Enzyme Replacement Therapy up to 4 years. 98
The clinical spectrum of CASQ1-related myopathy 98
LGMD2E patients risk developing dilated cardiomyopathy 97
The Role of Motor System in Mental Rotation: New Insights from Myotonic Dystrophy Type 1 97
Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS): validation and longitudinal performance 96
Genetic variation in KIFAP3 is associated with an upper motor neuron-predominant phenotype in amyotrophic lateral sclerosis 96
Totale 12.027
Categoria #
all - tutte 126.545
article - articoli 108.111
book - libri 125
conference - conferenze 0
curatela - curatele 0
other - altro 722
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.614
Totale 238.117


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.115 0 0 0 0 0 0 0 0 0 555 293 267
2020/20214.196 141 338 132 689 212 292 77 431 561 404 476 443
2021/20225.752 478 694 690 428 172 380 340 500 191 177 589 1.113
2022/20233.347 807 231 55 372 557 457 16 237 386 40 148 41
2023/20241.918 73 239 214 140 136 171 104 77 103 121 253 287
2024/20254.954 49 484 456 316 1.134 236 479 735 816 249 0 0
Totale 31.664